Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Iwaki M, Kessoku T, Tanaka K, Ozaki A, Kasai Y, Kobayashi T, Nogami A, Honda Y, Ogawa Y, Imajo K, Usuda H, Wada K, Kobayashi N, Saito S, Nakajima A, Yoneda M.
Iwaki M, et al. Among authors: kobayashi n, kobayashi t.
Hepatol Commun. 2023 Oct 31;7(11):e0285. doi: 10.1097/HC9.0000000000000285. eCollection 2023 Nov 1.
Hepatol Commun. 2023.
PMID: 37902528
Free PMC article.